Buy AB-Chminaca Spray

Embark on an immersive journey with Buy AB-Chminaca Spray, a pioneering designer drug initially identified in synthetic cannabis blends in Japan in 2013. Remarkably, by 2018, it secured its position as the third-most prevalent synthetic cannabinoid found in substances seized by the vigilant Drug Enforcement Agency.

Unveiling the Potency: The (S)-Enantiomer

Explore the scientific nuances with the (S)-enantiomer of ADB-FUBINACA, intricately detailed in a 2009 Pfizer patent. Recognized as a potent agonist of the CB1 and CB2 receptors, it boasts impressive EC50 values of 1.2 nM and 3.5 nM, respectively. ADB-FUBINACA, from which AB-Chminaca derives, features a carboxamide group at the 3-indazole position, sharing structural elements with SDB-001 and STS-135. Notably, ADB-FUBINACA showcases deliberate drug design, differing from AB-FUBINACA only through the replacement of the isopropyl group with a tert-butyl group.

Advancements in Analogues: ADSB-FUB-187

Stay on the cutting edge of designer drugs as you learn about ADSB-FUB-187, an analogue of ADB-FUBINACA featuring a more functionally advanced carboxamide substituent. This recent development underscores the dynamic evolution within this scientific landscape.

Technical Insights: Understanding the Composition

For the technically inclined, AB-Chminaca is formally identified as N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide. With a molecular formula of C21H23FN4O2 and a purity exceeding 98%, it stands as a neat solid formulation, ensuring stability for at least three years when stored at -20°C.

Legality and Metabolism: Navigating Complex Pathways

Uncover the legal landscape as AB-Chminaca falls under the classification of a Schedule I controlled substance in the United States. Delve into the intricate metabolic pathways involving alkyl and indazole hydroxylation, terminal amide hydrolysis, subsequent glucuronide conjugations, and dehydrogenation.

Cautionary Tales: Responsible Exploration

While the potential of AB-Chminaca is vast, responsible use is paramount. One recorded case links it to death through coronary arterial thrombosis, and at least eight deaths in Hungary in 2015—all involving individuals below 21—are associated with the usage of this material.

Warning: This product is not intended for human or veterinary use. Buy AB-Chminaca Spray responsibly and enhance your exploration of designer drugs.

Trust Our Platform for a Seamless Experience

In the realm of procuring medical supplies online, trust is non-negotiable. Our platform assures a seamless and secure experience, delivering AB-Chminaca Spray discreetly. Utilize our encrypted platform and secure payment methods for a trustworthy transaction. For any inquiries or assistance along your journey into the world of designer drugs, our dedicated team stands ready to guide you responsibly.